Brief: Nymox Pharmaceutical Reports Qtrly Net Loss Per Share Basic & Diluted of $0.05
Aug 13 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* NYMOX PHARMACEUTICAL CORP QTRLY NET LOSS PER SHARE BASIC &
DILUTED $0.05
Further company coverage: NYMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba